Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

IBRXImmunityBio, Inc.Finished

HCW9218 for Advanced Pancreatic Cancer

Advanced Pancreatic Carcinoma

10Calmworry score, out of 100

No strong warning signs right now. The score counts warning signs; it is not a prediction.

Why this score

  • Main results were due Feb 2025, none posted yet

    Counts until it's fixed

    +10
Worry score10

Score over time

Stage
Phase 1/2
Patients
21 (final count)
Started
Oct 17, 2022
Main results expected
Feb 15, 2025
Fully finished
Feb 15, 2025
Results posted
not yet

What counts as success

The trial's main goal(s), called the “primary outcome.”

  • Occurrence of Adverse Events and Treatment-Related Adverse Events

    Measured over: 12 Months

  • Determine the maximum tolerated dose (MTD)

    Measured over: 12 Months

Changes Tremor has spotted

No changes since Tremor started watching this trial.
Show details (technical version)

Score inputs

  • results_overdue: base 10, now 10, since 2025-02-15, no fading

Raw record changes

  • none yet

Trial ID NCT05304936 · record last updated 2026-04-15 · checked 2026-11-09 15:47 UTC

See the official record on ClinicalTrials.gov (NCT05304936) ↗